BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2335223)

  • 1. The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation.
    Wiseman H; Laughton MJ; Arnstein HR; Cannon M; Halliwell B
    FEBS Lett; 1990 Apr; 263(2):192-4. PubMed ID: 2335223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential.
    Wiseman H
    Biochem Pharmacol; 1994 Feb; 47(3):493-8. PubMed ID: 8117317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant action of ketoconazole and related azoles: comparison with tamoxifen and cholesterol.
    Wiseman H; Smith C; Arnstein HR; Halliwell B; Cannon M
    Chem Biol Interact; 1991; 79(2):229-43. PubMed ID: 1884432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen inhibits lipid peroxidation in cardiac microsomes. Comparison with liver microsomes and potential relevance to the cardiovascular benefits associated with cancer prevention and treatment by tamoxifen.
    Wiseman H; Cannon M; Arnstein HR; Halliwell B
    Biochem Pharmacol; 1993 May; 45(9):1851-5. PubMed ID: 8494544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer.
    Wiseman H; Smith C; Halliwell B; Cannon M; Arnstein HR; Lennard MS
    Cancer Lett; 1992 Sep; 66(1):61-8. PubMed ID: 1451097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic antioxidants. Diethylstilboestrol, hexoestrol and 17 alpha-ethynyloestradiol.
    Wiseman H; Halliwell B
    FEBS Lett; 1993 Oct; 332(1-2):159-63. PubMed ID: 8405434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity.
    Custódio JB; Dinis TC; Almeida LM; Madeira VM
    Biochem Pharmacol; 1994 Jun; 47(11):1989-98. PubMed ID: 8010983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioprotective antioxidant activity of dietary phytoestrogens compared to oestrogen.
    Wiseman H; O'Reilly J
    Biochem Soc Trans; 1997 Feb; 25(1):107S. PubMed ID: 9057005
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test.
    Cecchini R; Aruoma OI; Halliwell B
    Free Radic Res Commun; 1990; 10(4-5):245-58. PubMed ID: 1705234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen introduced into liposomes. Similarity to cholesterol and ergosterol.
    Wiseman H; Cannon M; Arnstein HR; Halliwell B
    FEBS Lett; 1990 Nov; 274(1-2):107-10. PubMed ID: 2253763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant activity of newly synthesized 2,7-diazaphenothiazines.
    Morak-Młodawska B; Pluta K; Matralis AN; Kourounakis AP
    Arch Pharm (Weinheim); 2010 May; 343(5):268-73. PubMed ID: 20232371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
    Wiseman H; Quinn P; Halliwell B
    FEBS Lett; 1993 Sep; 330(1):53-6. PubMed ID: 8370459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of liver microsomal lipid peroxidation by 13-cis-retinoic acid.
    Samokyszyn VM; Marnett LJ
    Free Radic Biol Med; 1990; 8(5):491-6. PubMed ID: 2253899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and estrogens as membrane antioxidants: comparison with cholesterol.
    Wiseman H
    Methods Enzymol; 1994; 234():590-602. PubMed ID: 7808336
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen.
    Wiseman H; Cannon M; Arnstein HR; Halliwell B
    Biochim Biophys Acta; 1993 Jun; 1181(3):201-6. PubMed ID: 8318548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chelating and antiradical effect of rutin during peroxidation of lipids from microsomes and liposomes].
    Dorozhko AI; Brodskiĭ AV; Afanas'ev IB
    Biokhimiia; 1988 Oct; 53(10):1660-6. PubMed ID: 3233225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lipid peroxidation promoted by iron(III) and ascorbate.
    Beach DC; Giroux E
    Arch Biochem Biophys; 1992 Sep; 297(2):258-64. PubMed ID: 1323241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the preparation of bioactive lignans of oxidative coupling reaction. I. Preparation and lipid peroxidation inhibitory effect of benzofuran lignans related to schizotenuins.
    Maeda S; Masuda H; Tokoroyama T
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2500-5. PubMed ID: 7697764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
    Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
    Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibitors on the biotransformation of tamoxifen by female rat and mouse liver slices and homogenates.
    Jordan CG; Brown K; Beedham C; Brown JE
    Drug Metabol Drug Interact; 1999; 15(4):239-58. PubMed ID: 10716039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.